| | Hydrophobic acrylic IOL material delays but does not prevent PCO onset
|
| The rate of posterior capsule opacification (PCO) associated with hydrophobic acrylic IOLs (AcrySof, Alcon Laboratories) is lower than the rate seen with other lens materials for 3 to 5 years after implantation, but after that time, the rate approximates that seen with other lens materials, according to results of an ongoing prospective, consecutive-case study of 5,500 eye-bank eyes. The finding could affect IOL selection decisions, especially for the pediatric patient population, in whom a high rate of PCO typically is seen, and for patients in developing countries, where access to Nd:YAG lasers to address PCO is limited. | |  |
|
|
| | Nevus most common ocular surface tumor for children
| | Ophthalmology Times | | New Orleans—Many conjunctival tumors can occur in children. The most common are nevi, and only 3% are malignant, said Carol L. Shields, MD, here at the annual meeting of the American Academy of Ophthalmology. |
|
| Multicenter trials shed light on amblyopia in children
| Real-world, community practice-based treatments studied
| | Ophthalmology Times | | The Pediatric Eye Disease Investigator Group has conducted several studies recently that are helping to clarify the effectiveness of various approaches to amblyopia treatment and evaluate the effectiveness of therapies in different age groups. |
| | Amblyopia trial results should be interpreted with caution
| More research needed to clarify unresolved issues, lecturer says
| | Ophthalmology Times | | The methodology of several large, multicenter trials of amblyopia treatment leaves several questions unresolved, according to an orthoptist who reviewed the studies. These questions relate to the association between patient age and treatment results, the treatment protocol, measurement of therapy adherence, visual acuity results, and the definition of therapy success. |
| | Excessive drowsiness may be seen in some infants
| Physician urges caution with ophthalmic solution in children less than 6 months old
| | Ophthalmology Times | | Apraclonidine eye drops, commonly used to diagnose Horner's syndrome in infants, should be used with caution following several reports of adverse reactions such as lethargy, bradycardia, and reduced respiratory rate. |
|
| 
